Berlin-Based Thryve secures €4 million to enhance automated healthcare solutions
Summary
This significant investment will fuel the company’s ambitious plans for international expansion and enhance its capabilities in wearable integration for automated prevention and treatment. Digital therapeutics, such as the leading DiGA-certified Sidekick Rx, use Thryve’s data integration to enhance individualisation and proactive care, particularly in the treatment of conditions like obesity with its product Zanadio. With the market growing by over 20% annually and one in two individuals now using a health tracker, Thryve’s technology plays a crucial role in preventing illness through early detection and ensuring continuous access to actionable healthcare insights. The newly acquired capital will enable the company to expand its customer base, currently spread across more than 20 countries, and to enhance its analytics and preventative health capabilities. Thryve already offers assessments in areas such as mental, cardiovascular, and metabolic health and plans to broaden its marker coverage and allow customers to run their algorithms within its engine.